Open AccessThe Combination of CUDC-907 and Gilteritinib Shows Promising Antileukemic Activity in Vitro and In Vivo in Preclinical Models of FLT3-ITD AML
Author(s) -
Tristan Knight,
Xinan Qiao,
Jun Ma,
Holly Edwards,
Lisa Polin,
Juiwanna Kushner,
Sijana H. Dzinic,
Kathryn White,
Hai Lin,
Yue Wang,
Jeffrey W. Taub,
Yubin Ge
Publication year - 2019
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood-2019-123793
Subject(s) - propidium iodide , cancer research , mapk/erk pathway , protein kinase b , pi3k/akt/mtor pathway , annexin a5 , chemistry , annexin , medicine , flow cytometry , biology , kinase , immunology , apoptosis , signal transduction , microbiology and biotechnology , biochemistry , programmed cell death
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom